nivolumab,ipilimumab,cabozantinib,sunitinib
bms,pfizer
['solid tumor', 'nivolumab', 'sunitinib', 'rcc,(-irccs),(-srcc),(-urcc)', 'cabozantinib', 'renal,(-adrenal)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'check,mate,9er', 'cabo ', 'nivo']
nivolumab plus cabozantinib vs sunitinib for first-line treatment of advanced renal cell carcinoma (arcc): 3-year follow-up from the phase 3 checkmate 9er trial. #gu23 
Medical Oncologist - Urologic Oncology. Hospital Universitario La Paz - IdiPAZ, Madrid